Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1756-8722

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity ; volume:13 ; number:1 ; day:30 ; month:11 ; year:2020 ; pages:1-19 ; date:12.2020
Journal of hematology & oncology ; 13, Heft 1 (30.11.2020), 1-19, 12.2020

Creator: Kuo, Tracy C.
Chen, Amy
Harrabi, Ons
Sockolosky, Jonathan T.
Zhang, Anli
Sangalang, Emma
Doyle, Laura V.
Kauder, Steven E.
Fontaine, Danielle
Bollini, Sangeetha
Han, Bora
Fu, Yang-Xin
Sim, Janet
Pons, Jaume
Wan, Hong I.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13045-020-00989-w

URN: urn:nbn:de:101:1-2021010907110042250101

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:31 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Kuo, Tracy C.
Chen, Amy
Harrabi, Ons
Sockolosky, Jonathan T.
Zhang, Anli
Sangalang, Emma
Doyle, Laura V.
Kauder, Steven E.
Fontaine, Danielle
Bollini, Sangeetha
Han, Bora
Fu, Yang-Xin
Sim, Janet
Pons, Jaume
Wan, Hong I.
SpringerLink (Online service)

Other Objects (12)

Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia

DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity

Targeting of phosphatidylserine by monoclonal antibodies reverses an immunosuppressive checkpoint inducing innate and specific anti-tumor responses

Integrin CD11b activation drives anti-tumor innate immunity

Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma

CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian Cancer

MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade

Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer

Radiation combined with macrophage depletion promotes adaptive immunity and potentiates checkpoint blockade

Midostaurin potentiates rituximab antitumor activity in Burkitt’s lymphoma by inducing apoptosis

Targeting autophagy potentiates antitumor activity of Met-TKIs against Met-amplified gastric cancer

Engineered Probiotic‐Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity

Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia

DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity

Targeting of phosphatidylserine by monoclonal antibodies reverses an immunosuppressive checkpoint inducing innate and specific anti-tumor responses

Integrin CD11b activation drives anti-tumor innate immunity

Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma

CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian Cancer

MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade

Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer

Radiation combined with macrophage depletion promotes adaptive immunity and potentiates checkpoint blockade

Midostaurin potentiates rituximab antitumor activity in Burkitt’s lymphoma by inducing apoptosis

Targeting autophagy potentiates antitumor activity of Met-TKIs against Met-amplified gastric cancer

Engineered Probiotic‐Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity

Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia

DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity

Targeting of phosphatidylserine by monoclonal antibodies reverses an immunosuppressive checkpoint inducing innate and specific anti-tumor responses

Integrin CD11b activation drives anti-tumor innate immunity

Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma

CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian Cancer

MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade

Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer

Radiation combined with macrophage depletion promotes adaptive immunity and potentiates checkpoint blockade

Midostaurin potentiates rituximab antitumor activity in Burkitt’s lymphoma by inducing apoptosis

Targeting autophagy potentiates antitumor activity of Met-TKIs against Met-amplified gastric cancer

Engineered Probiotic‐Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia

DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity

Targeting of phosphatidylserine by monoclonal antibodies reverses an immunosuppressive checkpoint inducing innate and specific anti-tumor responses

Integrin CD11b activation drives anti-tumor innate immunity

Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma

CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian Cancer

MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade

Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer

Radiation combined with macrophage depletion promotes adaptive immunity and potentiates checkpoint blockade

Midostaurin potentiates rituximab antitumor activity in Burkitt’s lymphoma by inducing apoptosis

Targeting autophagy potentiates antitumor activity of Met-TKIs against Met-amplified gastric cancer

Engineered Probiotic‐Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity

Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia

DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity

Targeting of phosphatidylserine by monoclonal antibodies reverses an immunosuppressive checkpoint inducing innate and specific anti-tumor responses

Integrin CD11b activation drives anti-tumor innate immunity

Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma

CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian Cancer

MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade

Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer

Radiation combined with macrophage depletion promotes adaptive immunity and potentiates checkpoint blockade

Midostaurin potentiates rituximab antitumor activity in Burkitt’s lymphoma by inducing apoptosis

Targeting autophagy potentiates antitumor activity of Met-TKIs against Met-amplified gastric cancer

Engineered Probiotic‐Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity

Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia

DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity

Targeting of phosphatidylserine by monoclonal antibodies reverses an immunosuppressive checkpoint inducing innate and specific anti-tumor responses

Integrin CD11b activation drives anti-tumor innate immunity

Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma

CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian Cancer

MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade

Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer

Radiation combined with macrophage depletion promotes adaptive immunity and potentiates checkpoint blockade

Midostaurin potentiates rituximab antitumor activity in Burkitt’s lymphoma by inducing apoptosis

Targeting autophagy potentiates antitumor activity of Met-TKIs against Met-amplified gastric cancer

Engineered Probiotic‐Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity

Related objects

Reset password